Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Researchers design proteins that can be utilized to combat Alzheimer's disease
Researchers design proteins that can be utilized to combat Alzheimer's disease
A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of t...
Merck to slim down with asset spinoff, focus on Keytruda, vaccines
Merck to slim down with asset spinoff, focus on Keytruda, vaccines
(Reuters) - Merck & Co Inc (MRK.
Sanofi investigated over epilepsy drug linked to birth defects
Sanofi investigated over epilepsy drug linked to birth defects
PARIS (Reuters) - French drugmaker Sanofi (SASY.
U.S. announces more coronavirus cases, details quarantine plans for returning travelers
U.S. announces more coronavirus cases, details quarantine plans for returning travelers
CHICAGO (Reuters) - The U.
Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone
Resverlogix Receives US FDA Breakthrough Therapy Designation for Apabetalone
CALGARY, Canada I February 03, 2020 - Resverlogix Corp.
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis
Insmed Announces Positive Top-Line Results from Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis
BRIDGEWATER, NJ, USA I February 3, 2020 - Insmed Incorporated (Nasdaq.
UK withdrawal from the EU on 31 January 2020
UK withdrawal from the EU on 31 January 2020
The United Kingdom will formally leave the European Union on 31 January 2020 and will become a third country to the EU.
Gilead climbs as coronavirus drug shows efficacy, starts trial
Gilead climbs as coronavirus drug shows efficacy, starts trial
Gilead has made progress in its effort to reposition failed Ebola drug remdesivir as a treatment for the coronavirus sweeping across China.
FDA approves first drug for treatment of peanut allergy for children
FDA approves first drug for treatment of peanut allergy for children
Today the U.
Bayer wins EU recommendation for prostate cancer drug
Bayer wins EU recommendation for prostate cancer drug
Bayer on Friday won an endorsement from the European Union’s drug regulator for its prostate cancer drug darolutamide, putting it on track for approval, as it takes on rival products by Pfizer and J...
Researchers identify possible new combination treatment for advanced melanoma
Researchers identify possible new combination treatment for advanced melanoma
FINDINGSA study by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusi...
Takeda to sell nearly-new Shire plant with 200 employees
Takeda to sell nearly-new Shire plant with 200 employees
Takeda, which has been cutting costs after closing its $60 billion deal for Shire last year, is putting a Shire plant up for sale.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand